I STILL LOVE YOU
By : RAYEN PONO
Intro : G Bm C Cm D
G C
kau kirimkan pesan singkatmu
D G
apakah kau baik-baik saja
Em C
jujur menetes air mataku
Cm D
karena ku tak sanggup jujur
G C
andai kamu ada waktu itu
D G
waktu ku hancur melepaskanmu
Em D C
pasti kamu mengerti mengapa
Cm D
tak pernah kau mampu menggantikamu
Chorus :
G D/F# Em
Rindu tapi tak bisa bertemu
Am G D
cinta tapi tak bisa bersama
G B Em
ingin lupa tapi ku sulit melupakan
D Am D
ingin berlari tapi tak mampu pergi
Int : G Bm C Cm D
G C
andai kamu ada waktu itu
D G
waktu ku hancur melepaskanmu
Em D C
pasti kamu mengerti mengapa
Cm D
tak pernah kau mampu menggantikamu
Chorus :
G D/F# Em
Rindu tapi tak bisa bertemu
Am G D
cinta tapi tak bisa bersama
G B Em
ingin lupa tapi ku sulit melupakan
D Am D
ingin berlari tapi tak mampu pergi
Em D/F# G
dia telah menyita semu rasaku
Em D/F# G D/F# Em
tak tersisa meski semua kini tlah hilang
Am D E
baik-baik di sana I still love you hoooo
Overtone:
A E/G# F#m
Rindu tapi tak bisa bertemu
Bm A G D/F# E
cinta tapi tak bisa bersama
D C#m C# F#m
ingin lupa tapi ku sulit melupakan
E Bm E A
ingin berlari tapi tak mampu pergi
A E/G# F#m
Rindu tapi tak bisa bertemu
Bm A G D/F# E
cinta tapi tak bisa bersama
D C#m C# F#m
ingin lupa tapi ku sulit melupakan
E Bm E A
ingin berlari tapi tak mampu pergi
D C#m C# F#m
ingin lupa tapi ku sulit melupakan
E Bm E A
ingin berlari tapi tak mampu pergi
Outro : A C#m D E G
It's the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations," like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans." Action began on that, too. There is still a long way to go. But this month there was a sign that ...
Comments
Post a Comment